Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate.
about
Fibroblast growth factor-10 is a mitogen for urothelial cellsStructural basis by which alternative splicing confers specificity in fibroblast growth factor receptorsFGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tractThe importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistanceFGF-10 is expressed at low levels in the human prostateFgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomasAndrogen regulation of prostate morphoregulatory gene expression: Fgf10-dependent and -independent pathwaysThe nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAsStromal fibroblasts in cancer initiation and progressionNovel phosphotyrosine targets of FGFR2IIIb signaling.Extending the family table: Insights from beyond vertebrates into the regulation of embryonic development by FGFsCellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.Fibroblast growth factor (FGF) receptor 1-IIIb is a naturally occurring functional receptor for FGFs that is preferentially expressed in the skin and the brain.Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats.Molecular signaling pathways that regulate prostate gland development.Dysregulated expression of growth factors and their receptors in the development of prostate cancer.Cultured stromal cells: an in vitro model of prostatic mesenchymal biology.Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities.Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptorAndrogen receptor signalling in the prostate.Induction of keratinocyte growth factor 1 Expression by lipopolysaccharide is regulated by CD-14 and toll-like receptors 2 and 4Growth factors and their receptors in prostate cancer.Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.LEF1 identifies androgen-independent epithelium in the developing prostate.PI3K/mTOR signaling regulates prostatic branching morphogenesisAndrogen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.Type 2 Fibroblast Growth Factor Receptor Signaling Preserves Stemness and Prevents Differentiation of Prostate Stem Cells from the Basal Compartment.ZNF143 transcription factor mediates cell survival through upregulation of the GPX1 activity in the mitochondrial respiratory dysfunction.The tumor microenvironment: key to early detection.Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.Fibroblast growth factors, old kids on the new block.Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.FGF signalling in prostate development, tissue homoeostasis and tumorigenesis.Targeting fibroblast growth factor pathways in prostate cancer.Progesterone regulates FGF10, MET, IGFBP1, and IGFBP3 in the endometrium of the ovine uterus.Association between age-related reductions in testosterone and risk of prostate cancer-An analysis of patients' data with prostatic diseases.Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells.Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines.
P2860
Q24292889-61BB6315-7486-46DE-B805-0C2E44D64E46Q24294933-CD27D258-F49E-40E2-9536-7229BF36C1C7Q24314647-3281B047-569A-44DB-BB42-1258F9E4418DQ28076745-2E410807-3D5F-4FF6-BE53-1792CF9490CAQ28144257-8EA4DD4A-F6FA-4CBC-9D51-CA11B18F92FBQ28267846-9D274C2C-2DF0-472D-8CE3-05FA37CC637FQ28564384-DEB66AF5-EF25-42E4-99B6-9CEF26E07682Q28575026-B74A2B34-FB8C-4A36-A003-BE119FE1DF8FQ29618873-339D6D5E-9618-48FE-A362-AF4942FCE6EDQ30376698-483FF67F-3415-4012-8408-C036D85FD71EQ30393982-18BE529F-391C-4757-9C0A-463E3CEB27E8Q30439922-41D6E066-16F6-408F-9A5B-9E1D0318A416Q30872713-31AA70C4-9611-4A6F-9772-1277757BA141Q31503184-15B4FF42-E50B-4C4C-96C1-86296B96CDEFQ33666315-4FA7C39A-7F1B-4B04-A288-5661BD666776Q33807246-5DAAAC95-9A94-4FB4-A906-992E9E2331FAQ34057789-3D3AB74F-94EE-47BC-A6E1-3087271B89F4Q34074836-95A76AB7-3C1E-4939-9BA7-F2B31D731856Q34097585-4E497BC8-D497-4773-AB01-A381711C17EAQ34105526-56C02B27-4123-4AA0-98E5-84FD5DB9C3D1Q34258269-45416AC7-A48C-41EB-9171-2A304D6D16FCQ34539272-42982076-A40F-43AD-BCA5-FD6104510BFAQ34978001-9CE3CCD2-0847-4611-92A0-4DDD1A1543ACQ35001290-52414754-DDB3-499C-8E9C-54B130BB9700Q35575601-E13D912B-4F08-4429-B867-9B6A761E0100Q35776234-21242A73-BF91-4579-8FA6-76A486CD9CC5Q35859471-A054602E-AE4C-44E3-B68B-39D3F0A8F4B0Q36525103-8D6D3063-EAFE-46E0-9F69-662FCA25AD12Q36627750-DA0D8F49-BABE-4001-B980-2B5C678CFC3AQ36867637-8B0B0879-074E-4731-BA07-789867394C04Q36923642-669B5481-20AA-499B-8DD5-540AB4B28D7DQ37456966-A133C6D4-F147-40BB-9F57-FB3683B598A6Q37734537-D6A30765-695E-4DFE-A1A7-FB92C9D26BEFQ38139831-B629789A-BBF8-4711-8DEE-3CD3D57B1FDFQ38287958-2EA1DDEF-257A-4365-9226-E648FF4E9933Q38683022-CD2EA532-4A18-4AC7-A3DB-F36432A848B4Q39235902-D82B2F6F-6453-4F24-BF26-FC2C6CFE2330Q39498733-DF5739A2-1953-41D2-B8E2-5CA74A4E73E3Q39568871-CFDC8736-F1A8-4195-A115-3CAC418348D8Q40333931-DB99954D-3920-47A9-A486-4FD057D39FC8
P2860
Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Fibroblast growth factor-10. A ...... l cell andromedin in prostate.
@en
type
label
Fibroblast growth factor-10. A ...... l cell andromedin in prostate.
@en
prefLabel
Fibroblast growth factor-10. A ...... l cell andromedin in prostate.
@en
P2093
P2860
P356
P1476
Fibroblast growth factor-10. A ...... l cell andromedin in prostate.
@en
P2093
P2860
P304
12827-12834
P356
10.1074/JBC.274.18.12827
P407
P577
1999-04-01T00:00:00Z